The role of radiation therapy in the management of sialorrhea
- PMID: 9719122
- DOI: 10.1016/s0360-3016(98)00153-9
The role of radiation therapy in the management of sialorrhea
Abstract
Purpose: Sialorrhea is the unintentional loss of saliva and other contents from the mouth. Most patients with this condition are elderly, requiring palliative treatment. These patients have neuropathology with associated poor performance status. Treatment prescribed for this disabling and distressing condition has often been of a surgical nature and described in young patients. It would be inapplicable to the elderly. The aim of this study was to review the role of radiation therapy in the management of sialorrhea. Previous reports are few in number and are cautionary because of adverse effects which have been described, including dryness of the mouth.
Methods and materials: A total of 34 patients were referred to the Department of Radiation Oncology, Palmerston North Hospital, between 1966 and August 1994, of whom only 1 patient received treatment prior to 1985. Three patients declined treatment and were, therefore, excluded from this review. Thirty-one patients, including 14 males and 17 females, of median age 72 years received 1 or more radiation treatments for sialorrhea. The patients were followed up for a median of 12 months, ranging from 6 months to 27 years.
Results: Initially, 82% (28/34) of treatments were associated with a satisfactory response. Six patients relapsed, of whom five experienced relapse within 6 months of initial treatment. Two patients were re-treated, one of whom achieved a complete response. Up to the time of review 64% (23/36) of treatments maintained a satisfactory response. The varied fractionation regimens used were not shown to affect the response rate; low doses were shown to be as effective as higher doses, and were not associated with any significant acute or late side effects. Only 4 patients developed long-term side effects. However, response rates were superior for patients treated with electrons, as opposed to orthovoltage therapy, and in particular when electron energies greater than 7 megavolts were used (76% vs. 38% maintained response, p < 0.05). Responses were also superior for patients treated with radiation fields which encompassed both parotid and submandibular glands (74% vs. 33 % maintained response, p < 0.01).
Conclusions: Radiation therapy has proven to be a safe and effective treatment in this group of patients, thereby avoiding the adverse effects of anticholinergic medication and invasive surgical procedures.
Similar articles
-
Salivary glands radiotherapy to reduce sialorrhea in amyotrophic lateral sclerosis: dose and energy.Cancer Radiother. 2013 Jun;17(3):191-5. doi: 10.1016/j.canrad.2013.01.010. Epub 2013 Mar 19. Cancer Radiother. 2013. PMID: 23517881
-
Radiation therapy for hypersalivation: a prospective study in 50 amyotrophic lateral sclerosis patients.Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):589-95. doi: 10.1016/j.ijrobp.2013.11.230. Epub 2014 Jan 7. Int J Radiat Oncol Biol Phys. 2014. PMID: 24411632
-
Radiotherapy to the salivary glands as treatment of sialorrhea in patients with parkinsonism.Mov Disord. 2007 Dec;22(16):2430-5. doi: 10.1002/mds.21752. Mov Disord. 2007. PMID: 17960826
-
Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S13-20. doi: 10.1007/s00280-002-0447-1. Epub 2002 Apr 12. Cancer Chemother Pharmacol. 2002. PMID: 12042984 Review.
-
[Treatment of sialorrhea in patients under long-term ventilation].Pneumologie. 2008 Mar;62 Suppl 1:S39-42. doi: 10.1055/s-2007-1016440. Pneumologie. 2008. PMID: 18317983 Review. German.
Cited by
-
Hypersalivation: update of the German S2k guideline (AWMF) in short form.J Neural Transm (Vienna). 2019 Jul;126(7):853-862. doi: 10.1007/s00702-019-02000-4. Epub 2019 Apr 10. J Neural Transm (Vienna). 2019. PMID: 30972507 Review.
-
Therapy of Sialorrhea with Botulinum Neurotoxin.Neurol Ther. 2019 Dec;8(2):273-288. doi: 10.1007/s40120-019-00155-6. Epub 2019 Sep 21. Neurol Ther. 2019. PMID: 31542879 Free PMC article. Review.
-
Botulinum Toxin A for Sialorrhoea Associated with Neurological Disorders: Evaluation of the Relationship between Effect of Treatment and the Number of Glands Treated.Toxins (Basel). 2018 Jan 27;10(2):55. doi: 10.3390/toxins10020055. Toxins (Basel). 2018. PMID: 29382036 Free PMC article. Clinical Trial.
-
Salivary Secretory Disorders, Inducing Drugs, and Clinical Management.Int J Med Sci. 2015 Sep 22;12(10):811-24. doi: 10.7150/ijms.12912. eCollection 2015. Int J Med Sci. 2015. PMID: 26516310 Free PMC article. Review.
-
[Drooling following radiation. Botulinum toxin as a successful treatment modality].HNO. 2011 Jan;59(1):115-7. doi: 10.1007/s00106-010-2232-5. HNO. 2011. PMID: 21181386 German.
MeSH terms
LinkOut - more resources
Full Text Sources